1. Introduction {#sec1}
===============

Wear debris-induced osteolysis is one of the principal causes of implant failure and consequent revision surgery in total joint arthroplasty \[[@B1], [@B2]\]. The osteolytic process is believed to start with the activation of macrophages and foreign-body giant cells and with phagocytosis of particulate wear debris. This appears to induce the release of proinflammatory cytokines and mediators that provoke the differentiation of phagocyte precursors into osteoclasts, which, in turn, results in periprosthetic osteolysis and implant loosening \[[@B3], [@B4]\]. Several proinflammatory mediators known to stimulate osteoclastic bone resorption, including interleukin (IL)-1, tumor necrosis factor (TNF)-*α*, IL-6, and prostaglandin (PG) E~2~ have been found in periprosthetic tissues \[[@B5]--[@B8]\]. These mediators are thought to promote the differentiation of precursor cells into mature osteoclasts by stimulating stromal cell expression of receptor activator of nuclear factor kappa-B ligand (RANKL), which is also abundant in the periprosthetic tissues around a loosened joint prosthesis \[[@B9]\].

Nuclear factor-kappa B (NF*κ*B) is a critical signaling molecule for an array of biological processes including inflammation, cellular differentiation, apoptosis, and tumorigenesis \[[@B10]--[@B12]\]. NF*κ*B also plays an important role in a majority of the pathophysiologic steps in particle-induced osteolysis. Namely, NF*κ*B is believed to be one of the transcription factors involved in regulating gene expression of proinflammatory cytokines including TNF-*α* and IL-1 in the monocyte/macrophage cell line \[[@B13]\]. Prior studies demonstrated particle-induced activation of NF*κ*B signaling, which preceded production of TNF-*α* or IL-6 \[[@B14], [@B15]\]. NF*κ*B is also important in regulating osteoclast differentiation \[[@B15]--[@B17]\]. It has also been reported that blockade of NF*κ*B signaling results in the inhibition of particle-induced osteoclastogenesis *in vitro* and osteolysis *in vivo*\[[@B15], [@B18], [@B19]\]. Therefore, it seems reasonable to employ NF*κ*B activation, whose significance is well established in this field, as an indicator of particle-induced inflammation and osteolysis.

In recent years, several highly-sensitive imaging technologies have been developed to detect and quantitate *in vivo* fluorescence and luminescence without sacrificing animals, and these technologies are coming to be widely used. NF*κ*B/luciferase transgenic (NF*κ*B/luc tg) mice, which carry a transgene-containing six NF*κ*B responsive elements and modified firefly luciferase complementary deoxyribonucleic acid (cDNA), exhibit luminescence at inflammatory sites in inflammatory disease models including arthritis and sepsis. Ho et al. evaluated the host-biomaterial interaction of genipin-cross-linked gelatin implant using this mouse \[[@B20]\]. We hypothesized that this might be applicable to the *in vivo* evaluation of inflammation and osteolysis induced by particles of bearing surface materials without sacrificing mice. The aim of this study was to test this hypothesis.

2. Materials and Methods {#sec2}
========================

2.1. Animals {#sec2.1}
------------

NF*κ*B/luc tg mice were purchased from Caliper Lifesciences (CA, USA) and maintained under specific pathogen-free conditions. In all experiments, 7-8 week old mice were used. All experiments were performed according to the guidelines of the Hokkaido University animal welfare committee.

2.2. Particles {#sec2.2}
--------------

Polyethylene (PE) particles (Ceridust 3615, mean diameter 7 *μ*m) were generously provided by Clariant Japan (Tokyo, Japan). The particles were processed under sterile conditions. They were washed for 24 h twice in 75% ethanol at room temperature using a rocking device and afterward dried in a vacuum desiccator according to a previously reported method \[[@B21]\]. The absence of endotoxin was confirmed by a Limulus assay (Limulus Amebocyte Lysate QCL-1000, Cambrex, NJ, USA). The particles were subdivided into separate use and stored at 4°C.

2.3. In Vivo Mouse Calvaria Resorption Model and Experimental Design {#sec2.3}
--------------------------------------------------------------------

The murine calvarial model is a representative model of particle-induced osteolysis in which wear particles of various materials, such as polymethyl methacrylate, titanium, or PE, are implanted onto mouse calvaria to induce bone resorption \[[@B22]\]. We treated mice with pentobarbital anesthesia (50 mg/kg of body weight, intraperitoneal injection), and then a 1 cm × 1 cm area of calvarial bone was exposed by making a midline sagittal incision over the calvaria. The periosteum was peeled of the external cortex of the calvaria and PE particles were spread over the area. The incision was then closed with simple 5--0 nylon sutures. Sham-operated animals were treated as described above except that no particles were implanted.

Firstly, five mice were subjected to histological analysis on day 7 after implantation of 5 mg PE particles. Secondly, 10 mice were divided into two groups (sham or 5 mg PE, *n* = 5, resp.), and luminescence was detected on days 0, 3, 7, 10, and 14 after PE implantation. Thirdly, 15 mice were divided into five groups (sham, 0.5 mg PE, 2 mg PE, 5 mg PE, and 10 mg PE, *n* = 3, resp.), and luminescence was detected on day 7 after PE implantation. Fourthly, 19 mice were implanted with 5 mg PE particles, from which three to five mice were subjected to the evaluation of luminescence and subsequent sacrifice on days 0, 3, 7, 10, or 14, respectively. The retrieved calvaria was cut into two pieces along the sagittal suture, which were then subjected to a luciferase assay or to real time reverse transcription-polymerase chain reaction (RT-PCR), respectively. And fifthly, 12 mice were divided into three groups (*n* = 4 per group, sham, 0.5 mg PE, and 5 mg PE), and following the evaluation of luminescence on day 7 after PE implantation, the calvariae were retrieved and were subjected to bone histomorphometry.

2.4. Histology {#sec2.4}
--------------

The calvariae were fixed in formalin, decalcified in ethylenediaminetetraacetic acid (EDTA), and embedded in paraffin. The calvaria were then sectioned into 5 *μ*m mid-frontal sections that were made such that the midline suture was at the center of the cross-section. For histological analysis, the sections were stained with hematoxylin/eosin (HE) and for tartrate-resistant acid phosphatase (TRAP) with use of the Diagnostics Acid Phosphatase Kit (Sigma Chemical, St. Louis, MO, USA).

2.5. In Vivo Imaging {#sec2.5}
--------------------

Following intravenous injection of 200 *μ*L of d-luciferin (D-Luciferin Potassium Salt, Wako Chemicals, Kanagawa, Japan) solution (10 mg/ml phosphate buffered saline (PBS)), we detected luminescence over the calvaria using an IVIS imaging system (IVIS spectrum, Xenogen, CA, USA). After setting the range of interest (ROI) to cover the luminescent area, the level of luminescence was quantified and expressed as total influx.

2.6. Luciferase Assay {#sec2.6}
---------------------

Luciferase activity of the calvaria was measured using a commercially available luciferase assay kit (PicaGene, TOYO B-Net, Tokyo, Japan) according to the manufacturer\'s protocol. In brief, the samples were soaked in lysis buffer (complete, mini, EDTA-free (Roche, Mannheim, Germany), 1 tablet in 10 ml of 50 mM Tris HCl pH 6.8) whose volume was fivefold the weight of the samples, homogenized using a pestle homogenizer, and centrifuged at 15000 rpm for 10 min. Finally, 20 *μ*l of the supernatant was mixed with 100 *μ*l of substrate, and luciferase activity was measured using a luminometer (Sirius luminometer, Berthold, Germany).

2.7. RNA Isolation and Real-Time RT PCR {#sec2.7}
---------------------------------------

Total ribonucleic acid (RNA) was extracted using the RNeasy minikit (Qiagen Inc., CA, USA) according to the manufacturer\'s instructions. Total RNA (1 *μ*g per sample) was reverse transcribed into single-stranded cDNA using the PrimeScript RT reagent Kit (TakaraBio, Shiga, Japan). Primers were obtained from the Perfect Real Time support system (Takara Bio, Shiga, Japan) on the basis of the published messenger RNA (mRNA) sequences, and their sequences are listed in [Table 1](#tab1){ref-type="table"}. RT-PCR was then performed using a Thermal Cycler Dice TP800 (TakaraBio, Shiga, Japan) and SYBR Premix Ex Taq (TakaraBio, Shiga, Japan) with 5 ng of cDNA template in a final volume of 25 *μ*l. The cDNA was amplified by 40 amplification cycles, and fluorescence changes were monitored with SYBR Green after each cycle. The results were evaluated using the Thermal Cycler Dice Real Time System software program. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) primers were used to normalize the results.

2.8. Bone Histomorphometry {#sec2.8}
--------------------------

The retrieved calvariae were fixed with 70% ethanol, stained with Villanueva bone stain for 7 days, dehydrated in graded concentrations of ethanol, and embedded in methyl methacrylate (Wako Chemicals, Kanagawa, Japan) without decalcification. Plastic blocks of 200 *μ*m thick midfrontal sections of the calvaria were cut with a precision bone saw such that the midline suture was in the center of the cross-section. Sections were mounted on plastic slides and ground to a thickness of 15 *μ*m using a precision lapping machine (Maruto, Tokyo, Japan) and hand ground according to the method of Frost \[[@B23]\]. The sections were analyzed using a semiautomatic image analyzing system (System Supply, Nagano, Japan) and a fluorescent microscope (Optiphot; Nikon, Tokyo, Japan) set at a magnification of 200x. The parameters measured for bone resorption were the number of osteoclasts per bone surface (N.Oc/BS, /mm), the osteoclast surface per bone surface (Oc.S/BS, %), and the eroded surface per bone surface (ES/BS, %).

2.9. Statistics {#sec2.9}
---------------

The data were evaluated for statistical significance by one-way analysis of variance (ANOVA) using Fisher\'s test as a post hoc test. The analysis of correlation was performed using the Pearson\'s product moment correlation coefficient. A *P* value of \<.05 was considered to be statistically significant.

3. Results {#sec3}
==========

3.1. Loading of PE Particles onto the Calvaria Induces Inflammatory Reaction and Osteoclastogenesis {#sec3.1}
---------------------------------------------------------------------------------------------------

Histological evaluation of murine calvaria on day 7 after loading of 5 mg of PE particles revealed the formation of fibrous granulomatous tissues centered around the sagittal suture area, which was accompanied by massive bone resorption and the formation of osteoclasts bordering the cortex (Figures [1(a)](#fig1){ref-type="fig"} and [1(b)](#fig1){ref-type="fig"}).

3.2. Loading of PE Particles onto the Calvaria Increases Luminescence {#sec3.2}
---------------------------------------------------------------------

*In vivo* imaging at the indicated number of days after loading of 5 mg PE particles showed a prominent increase in luminescence, reaching a maximum on day 7 ([Figure 2(a)](#fig2){ref-type="fig"}). In the sham group, only a slight increase in luminescence was observed. Quantitative analysis showed a significant increase in total influx in calvariae that received PE particles than those that received sham surgery ([Figure 2(b)](#fig2){ref-type="fig"}, \**P* \< .05, \*\**P* \< .001, \*\*\**P* \< .0001 versus sham at each time point). Imaging analysis performed on day 7 after loading of PE particles showed a dose-dependent increase in luminescence, reaching a maximum at 5 mg ([Figure 2(c)](#fig2){ref-type="fig"}). Quantitative analysis showed a significant increase in luminescence in response to loading of more than 2 mg of particles, reaching a maximum at 5 mg ([Figure 2(d)](#fig2){ref-type="fig"}, \**P* = .0005, \*\**P* \< .0001 versus sham).

3.3. Exposure to PE Particles Increases Calvaria Luciferase Activity, which Is Positively Correlated with Total Influx {#sec3.3}
----------------------------------------------------------------------------------------------------------------------

Luciferase activity was significantly enhanced on days 7, 10, and 14 ([Figure 3(a)](#fig3){ref-type="fig"}, \**P* \< .05, \*\**P* \< .0001 versus values on day 0). We examined the correlation between luminescence and luciferase activity, and found that the levels of total influx were positively correlated with the luciferase activity of the calvariae ([Figure 3(b)](#fig3){ref-type="fig"}, *n* = 19, *r* = 0.833, *P* \< .0001), indicating that luminescence actually reflected levels of luciferase activity.

3.4. Exposure to PE Particles Induces Upregulation of mRNA for NF*κ*B (p100/p52) and Bone-Resorbing Mediators, All of which Are Positively Correlated with Total Influx {#sec3.4}
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------

NF*κ*B/Rel transcription factors regulate their own synthesis. The promoter regions of *nfkb* contain binding sites for NF*κ*B that respond positively to activation of NF*κ*B/Rel \[[@B24]\]. To test if NF*κ*B is actually activated after particle loading, we evaluated NF*κ*B (p100/p52) mRNA expression. We also investigated mRNA levels of downstream bone-resorbing mediators TNF-*α*, IL-1*β*, RANKL, and cyclooxygenase (COX)-2, an inducible form of COX and is induced at inflammation sites and produces proinflammatory PGs. These mediators were nominated because of their pivotal role especially in murine osteolysis models, since selective inhibition of these factors were reported to result in the suppression of osteolysis using murine osteolysis models \[[@B25]--[@B28]\]. Real-time RT-PCR showed that NF*κ*B (p100/p52) mRNA level was significantly upregulated on days 3 to 14. The mRNA levels of TNF-*α*, IL-1*β*, RANKL, and COX-2 were also significantly upregulated ([Figure 4(a)](#fig4){ref-type="fig"}, ^†^*P* \< .05, ^††^*P* \< .01, ^†††^*P* \< .005  \**P* \< .001, \*\**P* \< .0005, \*\*\**P* \< .0001, versus value on day 0).

We examined the correlation between luminescence and mRNA levels, and found that the mRNA levels of all these factors were positively correlated with total influx. The correlation coefficient and *P* values were *r* = 0.808, *P* \< .0001 for NF*κ*B (p100/p52); *r* = 0.842, *P* \< .0001 for TNF-*α*; *r* = 0.855, *P* \< .0001 for IL-1*β*; *r* = 0.694, *P* \< .001 for RANKL; and *r* = 0.712, *P* \< .0005 for COX-2 ([Figure 4(b)](#fig4){ref-type="fig"}).

3.5. Exposure to PE Particles Increases Bone Resorption Parameters, All of which Are Positively Correlated with Total Influx {#sec3.5}
----------------------------------------------------------------------------------------------------------------------------

Most studies using murine calvarial model have evaluated bone resorption on day 7 after particle implantation, which is consistent with the report that osteolysis is reported to reach maximum on this day in this model \[[@B29]\]. Accordingly, to investigate the correlation between luminescence and osteolysis, we evaluated bone resorption on day 7. All the parameters for bone resorption were significantly enhanced by loading of more than 0.5 mg of PE particles ([Figure 5(a)](#fig5){ref-type="fig"}, \**P* \< .05, \*\**P* \< .005, versus sham). We examined the correlation between luminescence and levels of bone resorption parameters, and found that the levels of these parameters were positively correlated with total influx. The correlation coefficients and *P* values were *r* = 0.848, *P* \< .0005 for N.Oc/BS; *r* = 0.862, *P* \< .0001 for Oc.S/BS; and *r* = 0.837, *P* \< .0005 for ES/BS ([Figure 5(b)](#fig5){ref-type="fig"}).

4. Discussion {#sec4}
=============

Understanding the complex cellular and tissue mechanisms and interactions which occur in periprosthetic osteolysis requires multiple experimental approaches, each of which has its own set of advantages and limitations \[[@B30]\]. Among murine osteolysis models, calvarial model was developed to investigate the biology of wear debris-induced osteolysis independent of the critical mechanical and biomechanical components of aseptic loosening \[[@B31]\]. This model is limited by the fact that it does not exactly mimic the clinical situation responsible for osteolysis in humans, as the particles are implanted at a single-time point and the calvaria is a flat, membranous bone that is not exposed to synovial fluid. Nevertheless, this murine model is frequently used because it permits the use of a large array of molecular reagents and genetically defined strains and of highly quantitative outcome measures of osteoclast formation and bone resorption. Using this approach, a variety of laboratories has shown the prophylactic effects of inhibitors for TNF, RANKL, and COX-2, and of chemical agents, including bisphosphonates. Generally, the results of these experiments have been generated mainly by histological or molecular analysis. Accordingly, the use of many animals has been unavoidable for the evaluation of temporal changes after particle loading. Also, it has been difficult to observe any real-time changes that may occur in a single mouse.

*In vivo* imaging is an extremely useful approach that allows researchers to monitor biological reactions and evaluate the efficacy of drugs without sacrificing experimental animals. This technique, which allows the real-time visualization of pathological or physiological conditions including inflammation, tissue regeneration, angiogenesis, neoplasm, and others, has been widely used for the evaluation of experimental disease models; however, there have been few reports looking at particle-induced osteolysis using this technique. Very recently, Ren et al. published a report on the trafficking of intravenously administered luciferase-expressing macrophages after injection of cement particles in the femoral cavity of nude mice \[[@B32]\]. This report, which showed significant accumulation of macrophages at the femoral site where particles were loaded, may be the first one that observed particle-induced inflammation using *in vivo* imaging. NF*κ*B/luc tg mouse, which was first reported in 2002 and which has since been widely used for the evaluation of arthritis, sepsis, ultraviolet-induced dermatitis, and other diseases \[[@B33]\], is very useful for the assessment of inflammatory disease models. In this study, we were able to use this mouse to detect luminescence in the murine calvarial osteolysis model using PE particles. The luminescence reached maximum on day 7 and then gradually decreased, which was correlated with the kinetic change of mRNA levels of NF*κ*B (p100/p52) and downstream proinflammatory mediators. These suggested that the luminescence reflected the activation of NF*κ*B and subsequent inflammation. We also examined the correlation between bone resorption parameters and luminescence on day 7 and found that all these parameters were positively correlated with total influx. This suggested that the luminescence also reflected bone resorption.

Microcomputed tomography (*μ*CT) is a useful and promising method to precisely evaluate the amount of osteolysis induced by particle loading. Recently, Tsutsumi et al. evaluated the effect of bisphosphonate and osteoprotegerin on particle-induced osteolysis by this method \[[@B34]\]. In evaluating the amount of bone resorption, *μ*CT might be superior to *in vivo* imaging. On the other hand, the advantage of *in vivo* imaging is that it can provide molecular or biochemical information that are related to osteolysis, such as promoter activity of proinflammatory cytokines, enzymatic activity of proteases, and cellular trafficking of ex vivo administered cells depending on the need. Moreover, it might be more time saving than *μ*CT in that it acquires images almost in a moment. Therefore, these two methods should be compatible when evaluating experimental osteolysis model.

We found in this study that the luminescence was weaker in mice that received 10 mg of PE than in those that received 5 mg of PE; however, the inflammatory reaction in mice loaded with 10 mg of PE was similar to that in mice loaded with 5 mg with respect to mRNA levels of inflammatory cytokines (data not shown), which leads us to conclude that the thickness of the PE layer resulting from loading of greater amounts of PE particles might have attenuated the luminescence. The attenuation of light photons is the biggest obstacle in optical imaging. Approximately 90% of bioluminescence signal flux is lost per each centimeter of tissue thickness, and thus, the photon intensities detected by CCD cameras may not accurately reflect endogenous reporter gene expression in the inner organs \[[@B35]\]. Thus, it is important to be aware of this limitation, and to take into consideration the nature or the quantity of particles loaded.

5. Conclusion {#sec5}
=============

We have performed *in vivo* imaging analysis of the murine calvarial osteolysis model using NF*κ*B/luc tg mice to visualize the inflammatory reaction and osteolysis caused by foreign particles. This system could be a useful tool for screening therapeutic approaches to treat particle-induced inflammation and osteolysis.
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![Histological analysis of murine calvaria retrieved on day 7 after PE particle implantation. Midfrontal sections of parietal bone were made as described in [Section 2](#sec2){ref-type="sec"}. Magnification x100 and scale bar represents 200 *μ*m in all figures. A representative of five murine calvarial samples is shown. (a) Hematoxylin/eosin (HE). (b) Tartrate-resistant acid phosphatase (TRAP) staining.](JBB2011-727063.001){#fig1}

![(a) *In vivo* imaging analysis was performed on the indicated days after loading of 5 mg PE. (b) Quantitative analysis of luminescence in (a) (*n* = 3 per bar, Mean ± SD, \**P* \< .05, \*\**P* \< .001, \*\*\**P* \< .0001, 5 mg PE versus sham at each time point). (c) *In vivo* imaging analysis performed on day 7 after loading of the indicated amounts of PE. (d) Quantitative analysis of luminescence in (c) (*n* = 3 per bar, Mean ± SD, \**P* = .0005, \*\**P* \< .0001 versus sham).](JBB2011-727063.002){#fig2}

![(a) Luciferase activity of calvarial tissues retrieved on the indicated days and then subjected to a luciferase assay (*n* = 3--5 per bar, Mean ± SD, \**P* \< .05, \*\**P* \< .0001 versus value on day 0). (b) Correlation between total influx and luciferase activity of the calvariae (*n* = 19, *r* = 0.833, *P* \< .0001).](JBB2011-727063.003){#fig3}

![(a) The mRNA levels of NF*κ*B (p100/p52), TNF-*α*, IL-1*β*, RANKL, and COX-2 in calvarial tissues retrieved on the indicated days and subjected to real-time RT-PCR (*n* = 3--5 per bar, Mean ± SD, ^†^*P* \< .05, ^††^*P* \< .01, ^†††^*P* \< .005  \**P* \< .001, \*\**P* \< .0005, \*\*\**P* \< .0001 versus value on day 0). (b) Correlation between total influx and mRNA levels of NF*κ*B (p100/p52), TNF-*α*, IL-1*β*, RANKL, and COX-2. The correlation coefficient and *P* values were *r* = 0.808, *P* \< .0001 for NF*κ*B (p100/p52); *r* = 0.842, *P* \< .0001 for TNF-*α*; *r* = 0.855, *P* \< .0001 for IL-1*β*; *r* = 0.694, *P* \< .001 for RANKL; *r* = 0.712, *P* \< .0005 for COX-2.](JBB2011-727063.004){#fig4}

![(a) Levels of bone resorption parameters (N.Oc/BS, Oc.S/BS, and ES/BS) as assessed by bone histomorphometry in calvarial tissues retrieved on day 7 after PE loading (*n* = 4 per bar, Mean ± SD, \**P* \< .05, \*\**P* \< .005 versus sham). (b) Correlation between total influx and levels of bone resorption parameters. The correlation coefficient and *P* values were *r* = 0.848, *P* \< .0005 for N.Oc/BS; *r* = 0.862, *P* \< .0001 for Oc.S/BS; *r* = 0.837, *P* \< .0005 for ES/BS.](JBB2011-727063.005){#fig5}

###### 

List of primers used in real-time RT-PCR.

  Primer ID             Primers(5′--3′)                   Amplicon size (bp)   Accession no.
  --------------------- --------------------------------- -------------------- ---------------
  NF*κ*B (p100/p52)-F   GCT GAT GGC ACA GGA CGA GA        103                  NM019408.2
  NF*κ*B (p100/p52)-R   AGC GTG ATA AAT GAC GTG GGC TA                         
  TNF-*α*-F             AAG CCT GTA GCC CAC GTC GTA       122                  NM013693
  TNF-*α*-R             GGC ACC ACT AGT TGG TTG TCT TTG                        
  IL-1*β*-F             TCC AGG ATG AGG ACA TGA GCA C     105                  NM008361
  IL-1*β*-R             GAA CGT CAC ACA CCA GCA GGT TA                         
  RANKL-F               CAT GTG CCA CTG AGA ACC TTG AA    107                  NM011613
  RANKL-R               CAG GTC CCA GCG CAA TGT AAC                            
  COX-2-F               GCC AGG CTG AAC TTC GAA ACA       91                   NM011198
  COX-2-R               GCT CAC GAG GCC ACT GAT ACC TA                         
  GAPDH-F               TGT GTC CGT CGT GGA TCT GA        150                  NM001001303
  GAPDH-R               TTG CTG TTG AAG TCG CAG GAG                            

NF*κ*B: nuclear factor-kappa B, TNF: tumor-necrosis factor, IL: interleukin, RANKL: receptor activator of nuclear factor kappa-B ligand, COX: cyclooxygenase, GAPDH: glyceroaldehyde-3-phosphate dehydrogenase, bp: base pair.
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